Preferential recruitment of phagocytes into the lung of patients with advanced acquired immunodeficiency syndrome and tuberculosis

Respiratory Medicine

Volumn 94, Issue 1, 2000, Pages 64-70

  Werneck Barroso, E ^a   Bonecini De Almeida, M D A G ^b   Vieira, M A M S ^c   Carvalho, C E ^d   Teixeira, A K ^a   Kritski, A L ^e   Ho, J L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Cornell University Medical College ^*  (Brazil)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

AIDS; Bronchoalveolar lavage; Eosinophils; HIV; Inflammation; Macrophages; Neutrophils; Tuberculosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATORY CELL; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; LUNG TUBERCULOSIS; LYMPHOCYTE SUBPOPULATION; MALE; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL;

EID: 0034000544     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.1999.0669     Document Type: Article

References (36)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
2. Zacarias F, Gonzales RS, Cuchi P, et al. HIV/AIDS and its interaction with tuberculosis in Latin America and the Caribbean. Bull Pan Am Health Organ 1994; 28: 312-323.
3. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis. JAMA 1995; 273: 220-226.
4. Ho JL. Co-infection with HIV and Mycobacterium tuberculosis: Immunologie interactions, disease progression, and survival. Mem Inst Oswaldo Cruz 1996; 91: 385-387.
5. Murray JF. The white plague: down and out, or coming and up? Am Rev Respir Dis 1991; 144: 750-755.
6. Rieder HL, Cauthern GM, Bloch AB. Tuberculosis and acquired immunodeficiency syndrome Arch Int Med 1989; 149: 1268-1273.
7. Hopewell PC. Impact of Human Immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 1992; 15: 540-547.
8. Bennett D, Watson J. Tuberculosis in the immunocompetent patient. Curr Top Infect Dis 1994; 7: 184191.
9. Khan MA, Kovnat DM, Bachus B, Whitcomb ME, Broady JS, Snider DL. Clinical and roentgenographic spectrum of pulmonary tuberculosis in the adult. Am J Med 1977; 62: 31-38.
10. Kritski AL, Werneck-Barroso E, Bravo De Souza R, Andrade GN, Castilho EA, Galväo-Castro B. Tuber-culosis and HIV infection in Rio de Janeiro, Brazil. AIDS 1991; 5: 107-118.
11. Reynolds HJ, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84: 559-573.
12. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979; 97: 149-206.
13. Ainslie GM, Solomon JA, Baterman ED. Lymphocyte and lymphocyte subset number in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery. Chest 1992; 102: 54-59.
14. Hoheisel GB, Tabak L, Teschler H, Erkan F, Krogel C, Costabel U. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am J Respir Crit Care Med 1994; 149: 460-63.
15. Dhand R, Gaanguly NK, Gupta N, Jaswal S, Malik SK, Kohlih KK. Factors influencing the cellular response in bronchoalveolar lavage and peripheral blood of patients with pulmonary tuberculosis. Tubercle 1988; 69: 161-173.
16. Ozaki T, Nakahira S, Tani K, Ogushi F, Yasuoka S, Ogura T. Differential cell analysis in bronchoalveolar lavage fluid from pulmonary lesions of patients with tuberculosis. Chest 1993; 104: 1773-1778.
17. Law KF, Jagirdar J, Weiden MD, Bodkin M, Rom WN. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med 1996; 153: 1377-1384.
18. Nowkowski M, Chan S-P, Steiner P, Chice S, Durkin HG. Differential distributions blood lymphocytes subsets in pediatrie AIDS or tuberculosis. Ann Clin Lab Sci 1992; 22: 377-384.
19. CDC Revision of CDC Surveillance Case Definition for AIDS. MMWR 1987; 36: S3-15.
20. Jungi TW, McGregor DD. Dissociation of macrophage accumulation and local chemotactic activity in delayed inflammation sites. Cell Immunol 1979; 7: 274-284.
21. Chaisson RE, Schechter GF, Goodman PC et al. Tuberculosis in patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 1987; 136: 570-574.
22. Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with HIV infection. N Engl J Med 1991; 324: 1644-1650.
23. Edwards D, Kirkpatrick CH. The immunology of Mycobacterial Disease. Am Rev Respir Dis 1986; 134: 1062-1071.
24. Dannenberg AM Jr. Cellular hypersentivity and cellular immunity in the pathogenesis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes. Bacterial Rev 1968; 32: 85-102.
25. Willians T, Hellewell P. Immunopharmacology of Neutrophils, Academic Press, 1994.
26. Rich AR. The Pathogenesis of Tuberculosis, 2nd ed. Springfield, Illinois: Charles C. Thomas, Publisher.
27. Slavin RE, Walsh TJ, Pollack AD. Late generalized tuberculosis: a clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras. Medicine 1980; 59: 352-366.
28. Grinsztejn B, Fandinho FCO, Veloso VG, Nogueira AS, Fonseca LS, Werneck-Barroso E. Mycobacteremia in patients with the acquired immunodeficiency syndrome. Arch Intern Med 1997; 157: 2359-2363.
29. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in IFN-y gene-disrupted mice. J Exp Med 1993; 178: 2243-2248.
30. Flynn J, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-gamma in resistance to Mycobacierium tuberculosis infection. J Exp Med 1993; 178: 2249-2254.
31. Vijayan VK, Rectha AM, Jawahar MS, Sankaran K, Prabhakar R. Pulmonary eosinophilia in pulmonary tuberculosis. Chest 1992; 101: 1708-1709.
32. Lucas S., Nelson M. Pathogenesis of tuberculosis in Human Immunodeficiency Virus-Infected People In: Bloom, B.R., ed. Tuberculosis: Pathogenesis, Protection and Control. Washington, D.C: American Society for Microbiology, 1994; pp 503-513.
33. Jagirdar J, Zagzag D. Pathology and insights into pathogenesis of tuberculosis. In: WN Rom and S. Garay, eds. Tuberculosis, New York: Little, Brown and Company (Inc.), 1995; pp. 467.
34. Gachot B, Wolff B, Clair B, Regier B. Severe tuberculosis in patients with HIV infection. Intensive Care Med 1990; 16: 491-493.
35. Masud T, Kemp E. Corticosteroids in treatment of disseminated tuberculosis in patients with HIV infection. Brit Med J 1988; 296: 464-465.
36. Murray JF. HIV-associated tuberculosis: watch for it in the ICU. Intensive Care Med. 1990; 16: 487-488.